188 related articles for article (PubMed ID: 38112858)
21. [AIRE gene mutation in polyglandular syndrome type 1].
Martínez López MM; González Casado I; Alvarez Doforno R; Delgado Cerviño E; Gracia Bouthelier R
An Pediatr (Barc); 2006 Jun; 64(6):583-7. PubMed ID: 16792967
[TBL] [Abstract][Full Text] [Related]
22. Cytokine-specific autoantibodies shape the gut microbiome in autoimmune polyendocrine syndrome type 1.
Petersen AØ; Jokinen M; Plichta DR; Liebisch G; Gronwald W; Dettmer K; Oefner PJ; Vlamakis H; Chung DC; Ranki A; Xavier RJ
J Allergy Clin Immunol; 2021 Sep; 148(3):876-888. PubMed ID: 33819509
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune polyendocrine syndrome type 1: Utility of KCNRG autoantibodies as a marker of active pulmonary disease and successful treatment with rituximab.
Popler J; Alimohammadi M; Kämpe O; Dalin F; Dishop MK; Barker JM; Moriarty-Kelsey M; Soep JB; Deterding RR
Pediatr Pulmonol; 2012 Jan; 47(1):84-7. PubMed ID: 21901851
[TBL] [Abstract][Full Text] [Related]
24. [Autoimmune polyendocrine syndrome (APS)].
Warzée E; Legros JJ; Geenen V
Rev Med Liege; 2002 Nov; 57(11):710-4. PubMed ID: 12564102
[TBL] [Abstract][Full Text] [Related]
25. JAK Inhibition Immunotherapy for APS-1.
Su MA
N Engl J Med; 2024 May; 390(20):1918-1921. PubMed ID: 38810191
[No Abstract] [Full Text] [Related]
26. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.
Wolff AS; Sarkadi AK; Maródi L; Kärner J; Orlova E; Oftedal BE; Kisand K; Oláh E; Meloni A; Myhre AG; Husebye ES; Motaghedi R; Perheentupa J; Peterson P; Willcox N; Meager A
J Clin Immunol; 2013 Nov; 33(8):1341-8. PubMed ID: 24158785
[TBL] [Abstract][Full Text] [Related]
27. Late-onset autoimmune polyendocrine syndrome type 1: a case report and literature review.
Zhan F; Cao L
Immunol Res; 2021 Apr; 69(2):139-144. PubMed ID: 33599910
[TBL] [Abstract][Full Text] [Related]
28. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease.
F Magitta N; Pura M; S Bøe Wolff A; Vanuga P; Meager A; M Knappskog P; Husebye ES
Eur J Endocrinol; 2008 May; 158(5):705-9. PubMed ID: 18426830
[TBL] [Abstract][Full Text] [Related]
30. Genetic dissection of autoimmune polyendocrine syndrome type 2: common origin of a spectrum of phenotypes.
Ballarini A; Lee-Kirsch MA
Ann N Y Acad Sci; 2007 Sep; 1110():159-65. PubMed ID: 17911431
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune polyendocrine syndrome type 1: case report and review of literature.
Weiler FG; Dias-da-Silva MR; Lazaretti-Castro M
Arq Bras Endocrinol Metabol; 2012 Feb; 56(1):54-66. PubMed ID: 22460196
[TBL] [Abstract][Full Text] [Related]
32. Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1.
Humbert L; Cornu M; Proust-Lemoine E; Bayry J; Wemeau JL; Vantyghem MC; Sendid B
Front Immunol; 2018; 9():2570. PubMed ID: 30510552
[TBL] [Abstract][Full Text] [Related]
33. AIRE and immunological tolerance: insights from the study of autoimmune polyendocrinopathy candidiasis and ectodermal dystrophy.
Notarangelo LD; Mazza C; Forino C; Mazzolari E; Buzi F
Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):491-6. PubMed ID: 15640689
[TBL] [Abstract][Full Text] [Related]
34. Systemic interferon type I and B cell responses are impaired in autoimmune polyendocrine syndrome type 1.
Oftedal BE; Delaleu N; Dolan D; Meager A; Husebye ES; Wolff ASB
FEBS Lett; 2023 May; 597(9):1261-1274. PubMed ID: 37052889
[TBL] [Abstract][Full Text] [Related]
35. Extrathymic expression of Aire controls the induction of effective T
Dobeš J; Ben-Nun O; Binyamin A; Stoler-Barak L; Oftedal BE; Goldfarb Y; Kadouri N; Gruper Y; Givony T; Zalayat I; Kováčová K; Böhmová H; Valter E; Shulman Z; Filipp D; Husebye ES; Abramson J
Nat Immunol; 2022 Jul; 23(7):1098-1108. PubMed ID: 35761088
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune polyglandular syndrome type 1 with diabetes insipidus: a case report.
Chen J; Lu T; Liu C; Zhao Y; Huang A; Hu X; Li M; Xiang R; Feng M; Lu H
BMC Endocr Disord; 2021 Aug; 21(1):154. PubMed ID: 34344344
[TBL] [Abstract][Full Text] [Related]
37. The heterogeneity of autoimmune polyendocrine syndrome type 1: Clinical features, new mutations and cytokine autoantibodies in a Brazilian cohort from tertiary care centers.
Weiler FG; Peterson P; Costa-Carvalho BT; de Barros Dorna M; Correia-Deur JE; Sader SL; Espíndola-Antunes D; Guerra-Junior G; Dias-da-Silva MR; Lazaretti-Castro M
Clin Immunol; 2018 Dec; 197():231-238. PubMed ID: 30287219
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients.
Fierabracci A; Arena A; Toto F; Gallo N; Puel A; Migaud M; Kumar M; Chengappa KG; Gulati R; Negi VS; Betterle C
J Endocrinol Invest; 2021 Apr; 44(4):661-677. PubMed ID: 32767280
[TBL] [Abstract][Full Text] [Related]
39. JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.
Fischer M; Olbrich P; Hadjadj J; Aumann V; Bakhtiar S; Barlogis V; von Bismarck P; Bloomfield M; Booth C; Buddingh EP; Cagdas D; Castelle M; Chan AY; Chandrakasan S; Chetty K; Cougoul P; Crickx E; Dara J; Deyà-Martínez A; Farmand S; Formankova R; Gennery AR; Gonzalez-Granado LI; Hagin D; Hanitsch LG; Hanzlikovà J; Hauck F; Ivorra-Cortés J; Kisand K; Kiykim A; Körholz J; Leahy TR; van Montfrans J; Nademi Z; Nelken B; Parikh S; Plado S; Ramakers J; Redlich A; Rieux-Laucat F; Rivière JG; Rodina Y; Júnior PR; Salou S; Schuetz C; Shcherbina A; Slatter MA; Touzot F; Unal E; Lankester AC; Burns S; Seppänen MRJ; Neth O; Albert MH; Ehl S; Neven B; Speckmann C
J Allergy Clin Immunol; 2024 Jan; 153(1):275-286.e18. PubMed ID: 37935260
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) due to AIRET16M mutation in a consanguineous Greek girl.
Kollios K; Tsolaki A; Antachopoulos C; Moix I; Morris MA; Papadopoulou M; Roilides E
J Pediatr Endocrinol Metab; 2011; 24(7-8):599-601. PubMed ID: 21932610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
